期刊文献+

表达BCRP的胚肾细胞系HEK293/BCRP的建立及生物学特征 被引量:1

Establishment of a human embryonic kidney epithelial cell line HEK293/BCRP expresses BCRP and its biological characterization
下载PDF
导出
摘要 目的:建立HEK293/BCRP多药耐药细胞系并研究其生物学功能。方法:构建有BCRP基因的表达载体,利用脂质体转染方法将载体转入HEK293细胞,并用RT-PCR、间接免疫荧光染色和流式细胞术分析检测转染细胞系BCRP的表达,体外细胞毒试验检测其对米托蒽醌等的耐药指数,流式细胞术和激光共聚焦分别检测其对罗丹明123和阿霉素的外排作用。结果:HEK293/BCRP细胞系在BCRP mRNA和蛋白表达均明显升高(P<0.05),对米托蒽醌的耐药指数达112.07倍,经1.5 h和3 h外排,细胞内罗丹明123浓度分别降低了42.25%和69.01%,激光共聚焦显示细胞内阿霉素浓度降低。结论:成功构建了表达BCRP的胚肾细胞系HEK293/BCRP,并对多种抗肿瘤药物具有耐受性。 Objective:To establish a human multi-drug resistant embryonic kidney epithelial cell line HEK293/BCRP and investigate its biological characterization. Methods:The expression vector containing breast cancer resistance protein (BCRP) gene was constructed and transfected into HEK293 cells mediated by liposomes. The expression of BCRP was detected by RT-PCR, indirect immunofluorescence staining, and flow cytometry. The multidrug resistance index to mitoxantrone was measured by in vitro cytotoxicity test. Efflux of Rhodamine 123 (Rh123) and adriamycin (ADR) was determined by flow cytometry and laser scanning confocal micros- copy, respectively. Results : BCRP expression significantly increased at both mRNA and protein levels in HEK293/BCRP cells. The resistance index to mitoxantrone was 112.07 times. The intracellular concentrations of Rh123 decreased by 42.25% and 69.01% after 1.5-h and 3-h efflux, respectively. Laser scanning confocal microscopy showed that the concentration of ADR also decreased. Conclusion:We successfully establish HEK293/BCRP cell line highly expressed BCRP and has cross-resistance to several anti-cancer drugs.
出处 《肿瘤》 CAS CSCD 北大核心 2007年第9期687-690,共4页 Tumor
基金 国家自然科学基金资助项目(编号:30572203 30570772)
关键词 细胞系 肿瘤 基因表达 多药耐药相关蛋白质类 乳腺癌耐受蛋白 HEK293/BCRP细胞 Cell line, tumor Gene expression Muhidrug resistance-associated proteins Breast cancer resistance protein HEK293/BCRP cell
  • 相关文献

参考文献11

  • 1DOYLE L A,YANG W,ABRUZZO L V,et al.A multidrug transporter from human MCF.7 breast cancer cells[J].Proc Natl Acad Sci USA,1998,95(26):15665-15670. 被引量:1
  • 2FISCHER V,EINOLF H J,COHEN D.Efflux transporters and their clinical relevailce[J].Mini Rev Med Chem,2005,5(2):183-195. 被引量:1
  • 3STEINBACH D,SELL W,VOIGT A,et al.BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia[J].Leukemia,2002,16(8):1443-1447. 被引量:1
  • 4XIA C Q,YANG JJ,GAN L S.Breast cancer resistance protein in pharmacokinetics and drug-drug interactions expert opin[J].Drug Metab Toxicol,2005,1(4):595-611. 被引量:1
  • 5XU J,LIU Y,YANG Y,et al.Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2[J].J Biol Chem,2004,279(19):19781-19789. 被引量:1
  • 6LESLIE E M,DEELEY R G,COLE S P.Multidrug resistance proteins:Role of P-glycoprotein,MRP1,MRP2,and BCRP (ABCG2)in tissue defense[J].Toxicol Appl Pharmacol,2005,204(3):216-237. 被引量:1
  • 7ABBOTt B L.ABCG2(BCRP):a cytoprotectant in normal and malignant stem cells[J].Clin Adv Hematol Oncol,2006,4(1):63-72. 被引量:1
  • 8VAN DER KOLK DM,VELLENGA E,SCHEFFER GL,et al.Expression and activity of breast cancer resistance protein (BCRP)in de novo and relapsed acute myeloid leukemia[J].Blood,20012,99(10):3763-3770. 被引量:1
  • 9VAN DEN HEUVEL-EIBRINK M M,WIEMER E A,PRINS A,et al.Increased expression of the breast callcer resistance protein (BCRP)in relapsed or refractory acute myeloid leukemia(AML)[J].Leukemia,2002,16(5):833-839. 被引量:1
  • 10ROSS D D,YANG W,ABRUZZO L V,et al.Atypical multidrug resistance:breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines[J].J Natl Cancer lnst,1999,91(5):429-433. 被引量:1

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部